[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

UV Infection Control Devices Market by Type (Mobile, Stationary, Other Types), End User (Hospital, Clinics, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026

March 2020 | 154 pages | ID: U6B017BFF8AAEN
Allied Market Research

US$ 5,370.00

E-mail Delivery (PDF), Online Subscription, Hard Copy Mail Delivery, CD-ROM Mail Delivery

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
The global UV infection control devices market was valued at $317.42 million in 2018, and is projected to reach $524.84 million by 2026, registering a CAGR of 6.5% from 2019 to 2026.

The UV infection control device is one of the disinfectant systems that use ultraviolet rays to kill microorganism present in the various healthcare setting such as hospitals, clinics, ambulatory surgical centers, research center, emergency departments, and others. As health care-associated infections (HAIs) is rising every year, which are caused by microorganisms such as fungi, bacteria, viruses, and parasites that can affect patients seriously. The UV infection control device works base on UV light that reflects off walls and other surfaces and is absorbed by bacteria, whose light-sensitive porphyrin molecules become excited and, as a result, experience oxidative damage and cell death.

The major factor that contributes to the growth of UV infection control device market include increase in government focus on infection control programs and increase in the prevalence of hospital acquired infections (HAI). Furthermore, other factors that boost UV infection control device market growth include rising adoption of technologically advanced UV equipment. However, high cost of UV infection control devices and stringent government regulations hampers the growth of UV infection control devices market. Conversely, high growth potential in developing economies is expected to offer lucrative opportunities during the forecast period.

The UV infection control devices market size is studied on the basis of type, end users, and region. By type, the market is bifurcated into mobile, stationary, and other types. By end user, the market is segmented into hospitals, clinics, and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Russia, and rest of Europe), Asia-Pacific (China, Japan, India, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS
  • This report entails a detailed quantitative analysis along with the current global UV infection control devices market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessments.
  • The market size and estimations are based on a comprehensive analysis of key developments in the industry.
  • A qualitative analysis based on innovative products facilitates strategic business planning.
      • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market
Key Market Segments
  • By Type
    • Mobile
    • Stationary
    • Other types
  • By End User
    • Hospitals
    • Clinics
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • India
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • Saudi Arabia
      • South Africa
      • Rest of LAMEA
  • List of key players profiled in the report:
  • CVS Health Corporation
  • DocMorris
  • Express Scripts Holding Company
  • Giant Eagle Inc.
  • Optum Rx Inc.
  • Rowlands Pharmacy
  • The Kroger Co.
  • Walgreen Co.
  • Walmart Stores Inc.
      • Apollo Pharmacy
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
  • The Miele Group
  • Melag Medizintechnik OHG
CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
  1.4.1. Secondary research
  1.4.2. Primary research
  1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
  3.2.1. Top investment pockets
  3.2.2. Top player positioning, 2018
3.3. Porter's five force analysis
3.4. Market dynamics
  3.4.1. Drivers
    3.4.1.1. Increase in government focus on infection control programs
    3.4.1.2. Increase in the prevalence of hospital acquired infections (HAI)
    3.4.1.3. Rising adoption of technologically advanced UV equipment
  3.4.2. Restraints
    3.4.2.1. High cost of UV infection control devices
    3.4.2.2. Stringent government regulations
  3.4.3. Opportunity
    3.4.3.1. High growth prospects in emerging markets

CHAPTER 4: UV INFECTION CONTROL DEVICES MARKET, BY TYPE

4.1. Overview
  4.1.1. Market size and forecast
4.2. Mobile Type
  4.2.1. Key market trends, growth factors, and opportunities
  4.2.2. Market size and forecast, by region
  4.2.3. Market analysis, by country
4.3. Station Type
  4.3.1. Key market trends, growth factors, and opportunities
  4.3.2. Market size and forecast, by region
  4.3.3. Market analysis, by country
4.4. Other Types
  4.4.1. Key market trends, growth factors, and opportunities
  4.4.2. Market size and forecast, by region
  4.4.3. Market analysis, by country

CHAPTER 5: GLOBAL UV INFECTION CONTROL DEVICES MARKET, BY END USER

5.1. Overview
  5.1.1. Market size and forecast
5.2. Hospitals
  5.2.1. Market size and forecast, by region
  5.2.2. Market analysis, by country
5.3. Clinics
  5.3.1. Market size and forecast, by region
  5.3.2. Market analysis, by country
5.4. Others
  5.4.1. Market size and forecast, by region
  5.4.2. Market analysis, by country

CHAPTER 6: UV INFECTION CONTROL DEVICES MARKET, BY REGION

6.1. Overview
  6.1.1. Market size and forecast
6.2. North America
  6.2.1. Key market trends and opportunities
  6.2.2. North America UV infection control devices market, by country
    6.2.2.1. U.S. UV infection control devices market, by type
    6.2.2.2. U.S. UV infection control devices market, by end user
    6.2.2.3. Canada UV infection control devices market, by type
    6.2.2.4. Canada UV infection control devices market, by end user
    6.2.2.5. Mexico UV infection control devices market, by type
    6.2.2.6. Mexico UV infection control devices market, by end user
  6.2.3. North America market size and forecast, by type
  6.2.4. North America market size and forecast, by end user
6.3. Europe
  6.3.1. Key market trends and opportunities
  6.3.2. Europe UV infection control devices market, by country
    6.3.2.1. Germany UV infection control devices market, by type
    6.3.2.2. Germany UV infection control devices market, by end user
    6.3.2.3. France UV infection control devices market, by type
    6.3.2.4. France UV infection control devices market, by end user
    6.3.2.5. UK UV infection control devices market, by type
    6.3.2.6. UK UV infection control devices market, by end user
    6.3.2.7. Italy UV infection control devices market, by type
    6.3.2.8. Italy UV infection control devices market, by end user
    6.3.2.9. Russia UV infection control devices market, by type
    6.3.2.10. Russia UV infection control devices market, by end user
    6.3.2.11. Rest of Europe UV infection control devices market, by type
    6.3.2.12. Rest of Europe UV infection control devices market, by end user
  6.3.3. Europe market size and forecast, by type
  6.3.4. Europe market size and forecast, by end user
6.4. Asia-Pacific
  6.4.1. Key market trends and opportunities
  6.4.2. Asia-Pacific UV infection control devices market, by country
    6.4.2.1. Japan UV infection control devices market, by type
    6.4.2.2. Japan UV infection control devices market, by end user
    6.4.2.3. China UV infection control devices market, by type
    6.4.2.4. China UV infection control devices market, by end user
    6.4.2.5. India UV infection control devices market, by type
    6.4.2.6. India UV infection control devices market, by end user
    6.4.2.7. Rest of Asia-Pacific UV infection control devices market, by type
    6.4.2.8. Rest of Asia-Pacific UV infection control devices market, by end user
  6.4.3. Asia-Pacific market size and forecast, by type
  6.4.4. Asia-Pacific market size and forecast, by end user
6.5. LAMEA
  6.5.1. Key market trends and opportunities
  6.5.2. LAMEA UV infection control devices market, by country
    6.5.2.1. Brazil UV infection control devices market, by type
    6.5.2.2. Brazil UV infection control devices market, by end user
    6.5.2.3. Saudi Arabia UV infection control devices market, by type
    6.5.2.4. Saudi Arabia UV infection control devices market, by end user
    6.5.2.5. South Africa UV infection control devices market, by type
    6.5.2.6. South Africa UV infection control devices market, by end user
    6.5.2.7. Rest of LAMEA UV infection control devices market, by type
    6.5.2.8. Rest of LAMEA UV infection control devices market, by end user
  6.5.3. LAMEA market size and forecast, by type
  6.5.4. LAMEA market size and forecast, by end user

CHAPTER 7: COMPANY PROFILES

7.1. American Air & Water, Inc.
  7.1.1. Company overview
  7.1.2. Company snapshot
  7.1.3. Operating business segments
  7.1.4. Product portfolio
7.2. American Ultraviolet
  7.2.1. Company overview
  7.2.2. Company snapshot
  7.2.3. Operating business segments
  7.2.4. Product portfolio
7.3. Lumalier Corp
  7.3.1. Company overview
  7.3.2. Company snapshot
  7.3.3. Operating business segments
  7.3.4. Product portfolio
7.4. Nikkiso Co., Ltd.
  7.4.1. Company overview
  7.4.2. Company snapshot
  7.4.3. Operating business segments
  7.4.4. Product portfolio
  7.4.5. Business performance
7.5. PDI, Inc.
  7.5.1. Company overview
  7.5.2. Company snapshot
  7.5.3. Operating business segments
  7.5.4. Product portfolio
  7.5.1. Key strategic moves and developments
7.6. Seal Shield, LLC
  7.6.1. Company overview
  7.6.2. Company snapshot
  7.6.3. Operating business segments
  7.6.4. Product portfolio
7.7. STERIS plc.
  7.7.1. Company overview
  7.7.2. Company snapshot
  7.7.3. Operating business segments
  7.7.4. Product portfolio
  7.7.5. Business performance
7.8. THE CLOROX COMPANY
  7.8.1. Company overview
  7.8.2. Company snapshot
  7.8.3. Operating business segments
  7.8.4. Product portfolio
  7.8.5. Business performance
7.9. UVC Cleaning Systems
  7.9.1. Company overview
  7.9.2. Company snapshot
  7.9.3. Operating business segments
  7.9.4. Product portfolio
7.10. XENEX
  7.10.1. Company overview
  7.10.2. Company snapshot
  7.10.3. Operating business segments
  7.10.4. Product portfolio
  7.10.5. Key strategic moves and developments
LIST OF TABLES

TABLE 01. UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 02. UV INFECTION CONTROL DEVICES MARKET FOR MOBILE TYPE, BY REGION 2018–2026 ($MILLION)
TABLE 03. UV INFECTION CONTROL DEVICES MARKET FOR STATION TYPE, BY REGION 2018–2026 ($MILLION)
TABLE 04. UV INFECTION CONTROL DEVICES MARKET FOR OTHER TYPES, BY REGION 2018–2026 ($MILLION)
TABLE 05. UV INFECTION CONTROL DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 06. UV INFECTION CONTROL DEVICES MARKET FOR HOSPITALS, BY REGION 2018–2026 ($MILLION)
TABLE 07. UV INFECTION CONTROL DEVICES MARKET FOR CLINICS, BY REGION 2018–2026 ($MILLION)
TABLE 08. UV INFECTION CONTROL DEVICES MARKET FOR OTHER END USER, BY REGION 2018–2026 ($MILLION)
TABLE 09. UV INFECTION CONTROL DEVICES MARKET REVENUE, BY REGION, 2018–2026 ($MILLION)
TABLE 10. NORTH AMERICA UV INFECTION CONTROL DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 11. U.S. UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 12. U.S. UV INFECTION CONTROL DEVICES, BY END USER 2018–2026 ($MILLION)
TABLE 13. CANADA UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 14. CANADA UV INFECTION CONTROL DEVICES, BY END USER 2018–2026 ($MILLION)
TABLE 15. MEXICO UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 16. MEXICO UV INFECTION CONTROL DEVICES MARKET, BY END USER 2018–2026 ($MILLION)
TABLE 17. NORTH AMERICA UV INFECTION CONTROL DEVICES REVENUE, BY TYPE, 2019–2026($MILLION)
TABLE 18. NORTH AMERICA UV INFECTION CONTROL DEVICES MARKET REVENUE, BY END USER, 2019–2026($MILLION)
TABLE 19. EUROPE UV INFECTION CONTROL DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 20. GERMANY UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 21. GERMANY UV INFECTION CONTROL DEVICES MARKET, BY END USER 2018–2026 ($MILLION)
TABLE 22. FRANCE UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 23. FRANCE UV INFECTION CONTROL DEVICES MARKET, BY END USER 2018–2026 ($MILLION)
TABLE 24. UK UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 25. UK UV INFECTION CONTROL DEVICES MARKET, BY END USER 2018–2026 ($MILLION)
TABLE 26. ITALY UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 27. ITALY. UV INFECTION CONTROL DEVICES MARKET, BY END USER 2018–2026 ($MILLION)
TABLE 28. RUSSIA UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 29. RUSSIA UV INFECTION CONTROL DEVICES MARKET, BY END USER 2018–2026 ($MILLION)
TABLE 30. REST OF EUROPE UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 31. REST OF EUROPE UV INFECTION CONTROL DEVICES MARKET, BY END USER 2018–2026 ($MILLION)
TABLE 32. EUROPE UV INFECTION CONTROL DEVICES MARKET REVENUE, BY TYPE, 2019–2026($MILLION)
TABLE 33. EUROPE UV INFECTION CONTROL DEVICES MARKET REVENUE, BY END USER, 2019–2026($MILLION)
TABLE 34. ASIA-PACIFIC UV INFECTION CONTROL DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 35. JAPAN UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 36. JAPAN UV INFECTION CONTROL DEVICES MARKET, BY END USER 2018–2026 ($MILLION)
TABLE 37. CHINA UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 38. CHINA UV INFECTION CONTROL DEVICES MARKET, BY END USER 2018–2026 ($MILLION)
TABLE 39. INDIA UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 40. INDIA UV INFECTION CONTROL DEVICES MARKET, BY END USER 2018–2026 ($MILLION)
TABLE 41. REST OF ASIA-PACIFIC UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 42. REST OF ASIA-PACIFIC UV INFECTION CONTROL DEVICES MARKET, BY END USER 2018–2026 ($MILLION)
TABLE 43. ASIA-PACIFIC UV INFECTION CONTROL DEVICES MARKET REVENUE, BY TYPE, 2019–2026($MILLION)
TABLE 44. ASIA-PACIFIC UV INFECTION CONTROL DEVICES MARKET REVENUE, BY END USER, 2019–2026($MILLION)
TABLE 45. LAMEA UV INFECTION CONTROL DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 46. BRAZIL UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 47. BRAZIL UV INFECTION CONTROL DEVICES MARKET, BY END USER 2018–2026 ($MILLION)
TABLE 48. SAUDI ARABIA UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 49. SAUDI ARABIA UV INFECTION CONTROL DEVICES MARKET, BY END USER 2018–2026 ($MILLION)
TABLE 50. SOUTH AFRICA UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 51. SOUTH AFRICA UV INFECTION CONTROL DEVICES MARKET, BY END USER 2018–2026 ($MILLION)
TABLE 52. REST OF LAMEA UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 53. REST OF LAMEA UV INFECTION CONTROL DEVICES MARKET, BY END USER 2018–2026 ($MILLION)
TABLE 54. LAMEA UV INFECTION CONTROL DEVICES MARKET REVENUE, BY TYPE, 2019–2026($MILLION)
TABLE 55. LAMEA UV INFECTION CONTROL DEVICES MARKET REVENUE, BY END USER, 2019–2026($MILLION)
TABLE 56. AMERICAN AIR & WATER, INC.: COMPANY SNAPSHOT
TABLE 57. AMERICAN AIR & WATER, INC.: OPERATING SEGMENTS
TABLE 58. AMERICAN AIR & WATER, INC.: PRODUCT PORTFOLIO
TABLE 59. AMERICAN ULTRAVIOLET: COMPANY SNAPSHOT
TABLE 60. AMERICAN ULTRAVIOLET: OPERATING SEGMENTS
TABLE 61. AMERICAN ULTRAVIOLET: PRODUCT PORTFOLIO:
TABLE 62. LUMALIER: COMPANY SNAPSHOT
TABLE 63. LUMALIER: OPERATING SEGMENTS
TABLE 64. LUMALIER: PRODUCT PORTFOLIO
TABLE 65. NIKKISO: COMPANY SNAPSHOT
TABLE 66. NIKKISO: OPERATING SEGMENTS
TABLE 67. NIKKISO: PRODUCT PORTFOLIO
TABLE 68. PDI: COMPANY SNAPSHOT
TABLE 69. PDI: OPERATING SEGMENTS
TABLE 70. PDI: PRODUCT PORTFOLIO
TABLE 71. SEAL SHIELD: COMPANY SNAPSHOT
TABLE 72. SEAL SHIELD, LLC: PRODUCT SEGMENTS
TABLE 73. SEAL SHIELD: PRODUCT PORTFOLIO
TABLE 74. STERIS: COMPANY SNAPSHOT
TABLE 75. STERIS: OPERATING SEGMENTS
TABLE 76. STERIS: PRODUCT PORTFOLIO
TABLE 77. THE CLOROX COMPANY: COMPANY SNAPSHOT
TABLE 78. THE CLOROX COMPANY: OPERATING SEGMENTS
TABLE 79. THE CLOROX COMPANY: PRODUCT PORTFOLIO
TABLE 80. UVC CLEANING SYSTEMS: COMPANY SNAPSHOT
TABLE 81. UVC CLEANING SYSTEMS: OPERATING SEGMENTS
TABLE 82. UVC CLEANING SYSTEMS: PRODUCT PORTFOLIO
TABLE 83. XENEX.: COMPANY SNAPSHOT
TABLE 84. XENEX.: OPERATING SEGMENTS
TABLE 85. XENEX: PRODUCT PORTFOLIO
LIST OF FIGURES

FIGURE 01. TOP INVESTMENT POCKETS
FIGURE 02. TOP PLAYER POSITIONING, 2018
FIGURE 03. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 04. MODERATE BARGAINING POWER OF BUYERS
FIGURE 05. MODERATE THREAT OF NEW ENTRANTS
FIGURE 06. HIGH THREAT OF SUBSTITUTION
FIGURE 07. MODERATE INTENSITY OF COMPETITIVE RIVALRY
FIGURE 08. COMPARATIVE SHARE ANALYSIS OF UV INFECTION CONTROL DEVICES MARKET FOR MOBILE TYPE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 09. COMPARATIVE SHARE ANALYSIS OF UV INFECTION CONTROL DEVICES MARKET FOR STATION TYPE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF UV INFECTION CONTROL DEVICES MARKET FOR OTHERS THERAPY, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF UV INFECTION CONTROL DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF UV INFECTION CONTROL DEVICES MARKET FOR CLINICS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF UV INFECTION CONTROL DEVICES MARKET FOR OTHER END USER, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14. NIKKISO: NET SALES, 2017–2018 ($MILLION)
FIGURE 15. NIKKISO REVENUE SHARE BY SEGMENTS, 2018 (%)
FIGURE 16. NIKKISO: REVENUE SHARE BY REGIONS, 2018 (%)
FIGURE 17. STERIS: NET SALES, 2017–2019 ($MILLION)
FIGURE 18. STERIS: REVENUE SHARE BY SEGMENT, 2019(%)
FIGURE 19. STERIS: REVENUE SHARE BY REGION, 2019(%)
FIGURE 20. NET SALES, 2017–2019 ($MILLION)
FIGURE 21. THE CLOROX COMPANY: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 22. THE CLOROX COMPANY: REVENUE SHARE BY REGION, 2019 (%)


More Publications